Metastasis: Clinical Trials

5 trials for Metastasis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

5 terminated. 5 Phase 2, 2 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 25Terminated 5
Phase 12Terminated 2

Follow Metastasis: new trials by email Literature Review of Metastasis trials Research Report on Metastasis

Trials (filtered) newest first · largest first

All 5 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study Evaluating Safety and Therapeutic Activity of THOR-707 in Adult Subjects With Advanced or Metastatic Solid Tumors (THOR-707-101)
THOR-707, Checkpoint inhibitor, anti-EGFR antibody - Metastasis
Phase 1 / Phase 2TerminatedSynthorx, Inc, a Sanofi company1752019-06-202025-12-15
Pembrolizumab + Idelalisib for Lung Cancer Study
Pembrolizumab, Idelalisib - Non Small Cell Lung Cancer, Metastasis
Phase 1 / Phase 2TerminatedAsha Nayak42017-09-262024-02-28
CEST- Glucose Enhanced MRI for Metastatic Brain Tumours
Magnetic resonance imaging, Gadovist (Gadobutrol), 50% dextrose solution - Brain Neoplasms, Malignant, Metastasis
Phase 2TerminatedBritish Columbia Cancer Agency32016-10-012019-01-28
A Safety Study of ZD4054 in Prior Chemotherapy Treated Patients With Metastatic Hormone-resistant Prostate Cancer
ZD4054 - Prostate Cancer, Metastasis
Phase 2TerminatedAarhus University Hospital242009-10-012014-01-08
Study of GPX-100 in the Treatment of Metastatic Breast Cancer
GPX-100 (13-deoxydoxorubicin) - Breast Cancer, Metastasis
Phase 2TerminatedGem Pharmaceuticals402005-03-012007-01-09

Narrower conditions

Neoplasm Metastasis (5)  ·  Neoplasms (2)  ·  Brain Neoplasms (1)  ·  Breast Neoplasms (1)  ·  Carcinoma, Non-Small-Cell Lung (1)  ·  Prostatic Neoplasms (1)  ·  Recurrence (1)

Broader conditions

Neoplastic Processes (5)  ·  Pathologic Processes (5)  ·  Pathological Conditions, Signs and Symptoms (5)  ·  Neoplasms by Site (4)  ·  Neoplasms (3)  ·  Brain Diseases (1)  ·  Breast Diseases (1)  ·  Bronchial Neoplasms (1)  ·  Carcinoma, Bronchogenic (1)  ·  Central Nervous System Diseases (1)  ·  Central Nervous System Neoplasms (1)  ·  Disease Attributes (1)  ·  Genital Diseases (1)  ·  Genital Diseases, Male (1)  ·  Genital Neoplasms, Male (1)

Interventions

pembrolizumab (2)  ·  Cetuximab (1)  ·  Magnetic Resonance Spectroscopy (1)  ·  ZD4054 (1)  ·  gadobutrol (1)  ·  idelalisib (1)

Sponsors

Aarhus University Hospital (1)  ·  Asha Nayak (1)  ·  British Columbia Cancer Agency (1)  ·  Gem Pharmaceuticals (1)  ·  Synthorx, Inc, a Sanofi company (1)

Countries

United States (3)  ·  Argentina (1)  ·  Australia (1)  ·  Bulgaria (1)  ·  Canada (1)  ·  Chile (1)  ·  Denmark (1)  ·  Singapore (1)  ·  Spain (1)

Top investigators

John H. Ward, MD (1)  ·  Michael Borre, MD Phd DMSc (1)  ·  Michael McKenzie (1)  ·  Zhonglin Hao, MD, PhD (1)

NIH funding

2023 (1)